Jeon Jae-Pil, Nam Hye-Young, Shim Sung-Mi, Han Bok-Ghee
Korea BioBank, Center for Genome Science, Korea National Institute of Health, Korea Center for Disease Control and Prevention, Seoul, 122-701, Korea.
Mol Cells. 2009 Feb 28;27(2):143-8. doi: 10.1007/s10059-009-0018-y. Epub 2009 Feb 20.
EBV-transformed lymphoblastoid cell lines (LCLs) are used as a resource for human genetic, immunological, and pharmacogenomic studies. We investigated the biological activity of 20 LCL strains during continuous long-term subculture up to a passage number of 160. Out of 20 LCL strains, 17 proliferated up to a passage number of 160, at which point LCLs are generally considered as "immortalized". The other three LCL strains lost the ability to proliferate at an average passage number of 41, during which these LCLs may have undergone cellular crisis. These non-immortal LCL strains exhibited no telomerase activity, decreased EBV gene expression, and a lower copy number of the EBV genome and mitochondrial DNA when compared with immortal LCLs. Thus, this study suggests that sustained EBV viral activity as well as telomerase activity may be required for complete LCL immortalization.
EB病毒转化的淋巴母细胞系(LCLs)被用作人类遗传学、免疫学和药物基因组学研究的资源。我们研究了20株LCL在连续长期传代直至传代次数达到160次过程中的生物学活性。在20株LCL中,17株增殖至传代次数160次,此时LCL通常被认为是“永生化的”。另外三株LCL在平均传代次数41次时失去增殖能力,在此期间这些LCL可能经历了细胞危机。与永生化的LCL相比,这些非永生化的LCL株没有端粒酶活性,EB病毒基因表达降低,EB病毒基因组和线粒体DNA的拷贝数也较低。因此,本研究表明,LCL完全永生化可能需要持续的EB病毒活性以及端粒酶活性。